A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

Clinical trial NCT01371721 · COMPLETED

Trial details

NCT number: NCT01371721
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2012-02-01
Primary completion: 2015-10-01
Enrollment: 269

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.